VR Logo

Aytu BioPharma Inc. (AYTU) download report


Healthcare | Drugs & Pharma

Aytu BioPharma Inc. (AYTU) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally.

IPO Date: 01-Feb-2017

Chairman & CEO: Mr. Joshua R. Disbrow

Chief Financial Officer: Mr. Mark K. Oki CPA

Listing: NASDAQ: AYTU

Country: United States

Headquarters: Englewood, CO

Website: https://aytubio.com

Key Facts

Market cap: $20.03 Mln

Revenue (TTM): $92.70 Mln

Earnings (TTM): $-111.47 Mln

Cash: $27.61 Mln

Total Debt: $21.26 Mln

Insider's Holding: 4.82%

Liquidity: Low

52 Week range: $0.45 - 5.38

Shares outstanding: 38,574,900

10 Years Aggregate:

  • CFO: $-120.81 Mln
  • EBITDA: $-132.01 Mln
  • Net Profit: $-173.34 Mln

Stock Performance

Time Period Aytu BioPharma (AYTU) S&P BSE Healthcare* S&P Small-Cap 600*
YTD-60.90-17.06-16.53
1 month-4.37-3.28-6.32
3 months-53.28-10.69-12.09
1 Year-89.89-13.41-15.75
3 Years-68.8119.057.56
5 Years-81.489.236.66
10 Years--12.3910.48
As on 27-Jun-2022 *As on 28-Jun-2022
Year Aytu BioPharma (AYTU) S&P Small-Cap 600 S&P BSE Healthcare
2021-77.4225.2720.87
2020-38.519.5761.45
201922.7320.86-3.55
2018-98.18-9.70-5.89
2017-90.7111.730.49